Ocuphire Pharma Inc. buy krebskrebs
Start price
05.10.20
/
50%
€7.00
Target price
04.11.21
€10.32
Performance (%)
-46.29%
End price
05.11.21
€3.76
Summary
This prediction ended on 05.11.21 with a price of €3.76. Massive losses of -46.29% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ocuphire Pharma Inc. | 9.477% | 9.477% | -67.029% | - |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
Comments by krebskrebs for this prediction
In the thread Ocuphire Pharma Inc. diskutieren
In the thread Trading Ocuphire Pharma Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten
Stopped prediction by krebskrebs for Ocuphire Pharma Inc.
Ocuphire Pharma Inc.
Start price
Target price
Perf. (%)
€2.58
07.02.22
07.02.22
€3.20
07.02.23
07.02.23
26.55%
08.02.23
08.02.23
